Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

This study has been completed.
Australasian Leukaemia and Lymphoma Group
Information provided by (Responsible Party):
Trans-Tasman Radiation Oncology Group (TROG) Identifier:
First received: September 13, 2005
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)